KIDPIK CORP.: Nasdaq/NYSE listing notice — Kidpik fails Nasdaq minimum bid price rule; 180-day cure period until Sept 2023

KIDPIK CORP.

Received Nasdaq notice on March 22, 2023, for failing $1.00 minimum bid price for 30 consecutive business days (Feb 7 to Mar 21).
Must regain compliance by Sept 18, 2023, with closing bid price ≥$1.00 for at least 10 consecutive business days.
If not cured, may receive additional 180-day period if meets initial listing criteria except bid price and intends to effect reverse stock split.
Company will monitor bid price and consider options; failure to cure could lead to delisting with right to appeal.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

KIDPIK CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2), 5810(c)(3)(A)

Exact text from the filing

March 22, 2023, Kidpik Corp. (the “ Company ”, “ we ” or “ us ”) received written notice (the “ Notification Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001493152-23-008711

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.